All Blogs

Feb 02, 2022

Many tech companies, especially wearable technology companies, have spent the last two years focusing on using their skills to address issues created by the worldwide pandemic. Simultaneously, many healthcare firms that would not have been called tech companies in the past have shifted their focus to technology and...

Feb 01, 2022

Immunocore Receives FDA Approval for the First Uveal Melanoma Treatment, As Well As the First T-cell Receptor Therapeutics Uveal Melanoma, an aggressive eye cancer, has proven to be a tough nut to crack for researchers seeking a cure. However, with the approval of a new treatment, those with the disorder will ha...

Jan 31, 2022

Cardiovascular Diseases (CVDs), primarily constituting heart failure, ischemic heart disease, stroke, are considered as leading global cause of mortality and a major contributor to disability. Over the last 30 years, deaths and disabilities from Cardiovascular Disease have been steadily rising across the globe. Car...

Jan 28, 2022

The autoimmune diseases are frequently incapacitating and, in some circumstances, fatal. There are currently more than 80 identified autoimmune disorders, such as Rheumatoid Arthritis, Crohn's Disease, Plaque Psoriasis, Ulcerative Colitis, Myasthenia Gravis, and many more with symptoms ranging from mild to severe. ...

Jan 27, 2022

GPX Embolic Device Success in Challenging Tumor Case On January 20, 2022, In a multi-center clinical study, Fluidx Medical's GPX Embolic Device was utilized to efficiently devascularize a massive tumor with several feeding vessels. The GPX Embolic Device is a cutting-edge embolic device that allows for easy prep...

Jun 18, 2026

Medical robotics stands at the vanguard of one of the most transformative periods in the history of healthcare. From autonomous surgical systems performing minimally invasive procedures with sub-millimeter precision, to wearable exoskeletons restoring mobility to paralyzed patients, and AI-driven logistics robots s...

Jan 25, 2022

Merck’s Chronic Cough Med Gefapixant Receives A Red Flag From the FDA, Requests For More Data On 24th January 2022, Merck & Co. announced FDA rejection for its New Drug Application (NDA) of Gefapixant (experimental drug) for unexplained or chronic cough. FDA asked for additional information on the drug, rela...

Jan 24, 2022

Highlights: The key challenges in the clinical trials processes such as slow recruitment, data management, lack of diversity, compliance with several rules and regulations, and others faced by the organizations.The impact of technology in clinical trials from recruiting more quickly to remote monitoring and impr...

Jan 21, 2022

Beta Thalassemia (β-Thalassemia) is a blood disorder characterized by reduced synthesis of the hemoglobin subunit beta (hemoglobin beta chain) that results in microcytic hypochromic anemia, an abnormal peripheral blood smear with nucleated red blood cells, and reduced amounts of hemoglobin A (HbA) on hemoglobin ana...

Jan 20, 2022

Suneva Medical Inc. inked a merger agreement with Viveon Health On January 12, 2022, Suneva Medical Inc., a leading regenerative aesthetics company, and Viveon Health Acquisition Corp., a particular purpose acquisition company, entered into a definitive merger agreement to establish a new regenerative aesthetics...